Navigation Links
Rexahn to Use MedAvante Centralized Ratings in MDD Phase 2b Study
Date:10/26/2010

er global provider of centralized expert psychiatric rating and monitoring services to the pharmaceutical, biotechnology and medical device industries. Its flagship service, Remote Centralized Ratings, provides real-time assessments, either by telephone or videoconference, of subjects in global drug trials. Centralizing the assessors and blinding them to study protocols results in a level of standardization, calibration and objectivity that is not achievable with a decentralized group of study raters participating from unconnected investigative sites. In addition to Centralized Ratings, the company provides Continuous Quality Control (CQC), a monitoring service in which expert calibrated trainers review site-based study interviews via audio and video.  MedAvante solutions help sponsors achieve increased drug effect and reduced trial failure rates, enabling them to bring better drugs to market faster. MedAvante operates facilities in Hamilton, NJ; Madison, WI; and Moscow, Russia.  For more information, please visit www.medavante.com.

About Rexahn Pharmaceuticals, Inc.  

Rexahn Pharmaceuticals is a clinical stage pharmaceutical company dedicated to developing and commercializing best in class and market leading therapeutics for cancer, CNS disorders, sexual dysfunction and other unmet medical needs. Rexahn currently has three drug candidates in Phase II clinical trials, Archexin®, Serdaxin®, and Zoraxel™ – all potential best in class therapeutics – and a robust pipeline of preclinical compounds to treat multiple cancers and CNS disorders.  Rexahn also operates key R&D programs of nano-medicines, 3D-GOLD, and TIMES drug discovery platforms.  For more information, please visit www.rexahn.com.


'/>"/>
SOURCE MedAvante, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MedAvante Launches Service to Boost Reliability of Assessments to Reduce Risk of Failed Alzheimers Disease Trials
2. MedAvante Opens Moscow Office and Successfully Completes First Centralized Ratings Assessment
3. ICON and MedAvante Sign Alliance Agreement
4. FDA Approves NDA That Includes Psychiatric Data Collected by Centralized Raters
5. ERT Announces New Report by TUFTS Identifying Growth in Adoption of Centralized ECG Services
6. Access MediQuip Announces Release of the Countrys First Centralized Recall Management Service(SM) for Implantable Devices
7. ERT Launches Centralized Cardiac Safety 2.0: A Revolutionary New Approach to ECG Management in Clinical Trials
8. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
9. Decision Resources Forecast of Global Tanezumab Sales Slashed Following FDA Halt of Phase III Studies
10. Keryx Biopharmaceuticals Announces Completion of Patient Enrollment In Zerenex Phase 3 Short-Term Study
11. Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... Chek Diagnostics, the U.S.-based manufacturer of both ... diagnostic products, has again been named to the ... in America. The Inc. 5000 ranking is ... Diagnostics earned its place on the list by growing ... For Chek Diagnostics, who appears on the ...
(Date:9/15/2014)... Pa. , Sept. 15, 2014  Inovio Pharmaceuticals, ... it has met the stringent listing criteria for the ... to this U.S. stock exchange from the NYSE MKT. ... ticker symbol, "INO." NASDAQ Global Select ... the highest initial listing standards of any exchange in ...
(Date:9/15/2014)... DUBLIN , Sept. 15, 2014 ... the "Digital Pathology Market by Slide Scanners, Analytics, ... Global Forecasts & Trends to 2018" report to ... the global digital pathology market into different products and ... digital pathology products market, followed by analytics. The analytics ...
Breaking Medicine Technology:Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 2Inovio Pharmaceuticals (INO) Begins Trading on NASDAQ Global Select Market Exchange 3Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 2Global Digital Pathology Market by Slide Scanners, Analytics, Delivery Modes & by Whole Slide Image Storage - Forecasts & Trends to 2018 3
... (NASDAQ: GPRO ) announced today that the Company ... Growth Stock Conference in Chicago on June 15, 2011 at ... presentation is scheduled to be webcast live and may be ... website at www.gen-probe.com . The webcast will be available ...
... Educating the critical players in the pharmaceutical marketplace ... been considered a key component of a successful product ... diminished, education efforts have taken on new importance among ... Facing a competitive environment, organizations with new products are ...
Cached Medicine Technology:Gen-Probe to Webcast Presentation at the William Blair & Company 31st Annual Growth Stock Conference 2Educating Key Stakeholders to Support a Successful Pharmaceutical Product Launch 2
(Date:9/16/2014)... (PRWEB) September 16, 2014 The rapidly ... concern for health plans, employers and PBMs as spending ... of their drug lists. Once a concentrated, patient-specific practice, ... 25 webinar from Atlantic Information Services, Inc. (AIS), ... will offer details of what one leading health ...
(Date:9/16/2014)... The Living Ethics lecture series returns ... on what it means to live in an ethically ... and thought-provoking topics. , “The Museum’s job is to ... at their world differently. The Living Ethics series’ ... truly enlightening dialogue,” says Richard Conti, Chief Wonder Officer, ...
(Date:9/16/2014)... Botanica Day Spa ... kicking off September with fall-themed discounts and giveaways. ... chose to highlight lumablanc® which contains Pevonia’s exclusive ... with the skin. , Lumablanc® was recently released ... anti-aging line. The brightening formula, containing a blend ...
(Date:9/16/2014)... Reading, MA (PRWEB) September 16, 2014 ... announce its partnership with Fairfax Egg Bank. The collaboration ... and expand the donor egg offering at the Fertility ... operated since 2006 and offers the nation’s largest selection ... is advantageous for several reasons:, , ...
(Date:9/15/2014)... 2014 With the variety of drugs ... to know the details on each one. However, it ... substances falling into their teen’s hands. , Synthetic ... among high school students. With varied, misleading and potentially ... it can be difficult for parents to separate the ...
Breaking Medicine News(10 mins):Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 2Health News:Botanica Day Spa Rolls Out September Specials Highlighting Lumablanc® by Pevonia 3Health News:FCNE Announces Partnership with Fairfax Egg Bank 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 2Health News:Teen Rehab Center CEO Releases Top 4 Facts Parents Must Know About Synthetic Marijuana 3
... today that the United States Food and,Drug Administration ... first LDL cholesterol lowering medication also indicated for,improving ... mellitus (DM) in,combination with metformin, sulfonylureas, or insulin, ... with other anti-diabetic agents., The ADA estimates ...
... by New York City Mayor,Michael Bloomberg, Lance Armstrong ... discussed Lance,s request to the Surgeons General,Collective to ... "This year alone, 1.4 million Americans are expected ... lose their lives to the disease," said,Lance Armstrong, ...
... Diego Supercomputer Center and other parts of the University ... Disease, fusion energy and climate change - were awarded ... as part of its 2008 Innovative and Novel Computational ... total, the DOEs Office of Science awarded a record ...
... seeds, chemo wafers slowed disease, boosted survival , , ... radioactive seeds and chemotherapy wafers following surgery shows ... study finds. , The early-phase clinical trial, led ... University of Cincinnati and University Hospital, included 34 ...
... Postings Part of Available Resources-, JACKSONVILLE, Fla., ... this group of returning wounded veterans are the ... Project has expanded,their ever-evolving battery of programs and ... (WtoW) initiative., The Warriors to Work (WtoW) ...
... this morning that Chairman and CEO Fred Hassan,intends ... million of Schering-Plough,Common Shares with personal funds., ... I purchased $4.68 million in,Schering-Plough Common Shares at ... this investment in Schering-Plough reflects my long-term,confidence in ...
Cached Medicine News:Health News:MultiVu Video Feed: WELCHOL (R) (COLESEVELAM HCL) RECEIVES FDA APPROVAL FOR GLUCOSE CONTROL IN ADULTS WITH TYPE 2 DIABETES MELITUS 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 2Health News:Lance Armstrong and 17th U.S. Surgeon General Carmona Announce National Call to Action in the War Against Cancer 3Health News:DOE awards supercomputing time to UCSD, SDSC researchers 2Health News:DOE awards supercomputing time to UCSD, SDSC researchers 3Health News:Combo Therapy Shows Promise in Treating Brain Tumors 2Health News:Wounded Warrior Project (WWP) Expands Service Offerings for Injured Soldiers with the New 'Warriors to Work' Program 2Health News:Schering-Plough CEO to Buy $2 Million in Common Shares 2Health News:Schering-Plough CEO to Buy $2 Million in Common Shares 3
... Laboratories Platelia Aspergillus EIA is a one-stage ... monoclonal antibody EBA-2 to detect circulating galactomannan ... 3 hours. , ,When used in conjunction ... is an aid in the diagnosis of ...
... The GreenLight PV Laser System ... the Prostate) Procedure for the ... (BPH) allows the urologist to ... a TURP with the safety ...
... diagnosis is generally confirmed by a positive heterophil ... however, is not indicated by the heterophil antibody ... - 20 percent of children. Detection and ... fully ascertain the stage of EBV infection. ...
... Bard® Biopsy Instrument and Needle is specially ... goal: a large quality, reliable core sample. ... featuring ultra-sharp tips and polished surfaces for ... of biopsy systems and needle sizes assures ...
Medicine Products: